Loading stock…

BillionToOne, Inc. (BLLN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

BillionToOne, Inc.

BLLNMarket cap $4.72BPrice $99.9

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Develops molecular diagnostic tests that use a proprietary "molecular counting" technology to detect fetal genetic conditions from a simple maternal blood draw, replacing riskier invasive procedures like amniocentesis for millions of expecting parents.

In Bastion Portfolios?

52W Return-20%

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)na–

Revenue Forecast

Rev CAGR (1y)+49%10

Rev CAGR (3y)+34%10

Rev CAGR (5y)+28%10

Earnings Forecast

EPS Growth Y+1+831%10

EPS Growth Y+2+2%4

EPS Growth Y+3+56%9

Quality

Margins

EBIT Margin11%5

Net Income Margin8%5

Free Cash Flow Margin8%5

Debt

Net Debt/EBITDA-6.310

Efficiency

ROE12%5

ROA7%7

Earnings Stability66

GEAR+AVERAGE40

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)661

P/E Ratio (Forward 3y)371

P/BV8.82

EV Multiples

EV/EBITDA Fwd621

EV/EBIT Fwd1231

Yield

Free Cash Flow Yield0.7%3

Dividend Yieldna–

Momentum

Short term

1 month return+1%8

3 month return-15%2

YTD return+22%8

Mid term

Price vs 52wHigh66%3

1 year return-8%4

Long term

3 year return-8%2

5 year return-8%3

Risk Shield

Price Risk

Betana–

Volatility96%1

Free Cash Flow

Free Cash Flow Margin8%5

Free Cash Flow Yield0.7%3

Quality

ROCE9%5

Earnings Stability66

Net Debt/EBITDA-6.310

02Growth

Is it actually growing, and how fast?

BLLNBillionToOne

Revenue FY25$305M

GROWTH RATING↗

VERY STRONG89 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGRna–

Revenue, next 1Y+49%10

Revenue, next 3Y, CAGR+34%10

Revenue, next 5Y, CAGR+28%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+831%10

EPS growth, FY27E+2%4

EPS growth, FY28E+56%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 89% of companies worldwide.

Revenue is set to grow 34%/yr over the next 3 years, ahead of most of the market.10/10

Revenue held flat over the last 3 years and is set to grow 34%/yr from here.

The runway holds up: revenue is set to grow 28%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 56%/yr vs revenue 34%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK19 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return-15%2

YTD return+22%8

MID & LONG-TERM▾SCORE

% of 52-week high66%3

1-year return-8%4

3-year return-8%2

5-year return-8%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+1%) and so far this year (+22%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-8.3% over three years and -8.3% over five), behind 70% of the market.

It's down 8% over the past year, now 34% below its 52-week high. That is a touch behind the market.

The stock is underperforming over three months (-15%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on BillionToOne, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

BLLNBillionToOne

Revenue FY25$305M

GROWTH RATING↗

VERY STRONG89 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGRna–

Revenue, next 1Y+49%10

Revenue, next 3Y, CAGR+34%10

Revenue, next 5Y, CAGR+28%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+831%10

EPS growth, FY27E+2%4

EPS growth, FY28E+56%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 89% of companies worldwide.

Revenue is set to grow 34%/yr over the next 3 years, ahead of most of the market.10/10

Revenue held flat over the last 3 years and is set to grow 34%/yr from here.

The runway holds up: revenue is set to grow 28%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 56%/yr vs revenue 34%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK19 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return-15%2

YTD return+22%8

MID & LONG-TERM▾SCORE

% of 52-week high66%3

1-year return-8%4

3-year return-8%2

5-year return-8%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+1%) and so far this year (+22%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-8.3% over three years and -8.3% over five), behind 70% of the market.

It's down 8% over the past year, now 34% below its 52-week high. That is a touch behind the market.

The stock is underperforming over three months (-15%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on BillionToOne, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community